Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · IEX Real-Time Price · USD
3.540
+0.350 (10.97%)
At close: Jul 19, 2024, 4:00 PM
3.590
+0.050 (1.41%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Daré Bioscience Stock Forecast
DARE's stock price has decreased by -63.13% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Daré Bioscience stock have an average target of 54, with a low estimate of 36 and a high estimate of 72. The average target predicts an increase of 1,425.42% from the current stock price of 3.54.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 15, 2024.
Analyst Ratings
The average analyst rating for DARE stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 1 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 1 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $72 | Strong Buy | Reiterates | $72 | +1,933.90% | May 15, 2024 |
| Brookline Capital | Brookline Capital | Hold → Strong Buy Upgrades $36 | Hold → Strong Buy | Upgrades | $36 | +916.95% | May 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $72 | Strong Buy | Reiterates | $72 | +1,933.90% | May 1, 2024 |
| Brookline Capital | Brookline Capital | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Apr 17, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $72 | Strong Buy | Reiterates | $72 | +1,933.90% | Apr 1, 2024 |
Financial Forecast
Revenue This Year
15.85M
from 2.81M
Increased by 464.48%
Revenue Next Year
28.40M
from 15.85M
Increased by 79.15%
EPS This Year
-0.18
from -4.20
EPS Next Year
-0.14
from -0.18
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 37.8M | 62.5M | 114.2M | 326.9M | 593.7M |
| Avg | 15.9M | 28.4M | 55.5M | 180.6M | 356.1M |
| Low | 7.7M | n/a | n/a | 41.8M | 130.1M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 1,246.2% | 294.3% | 302.3% | 489.2% | 228.8% |
| Avg | 464.5% | 79.2% | 95.4% | 225.4% | 97.2% |
| Low | 174.2% | - | - | -24.6% | -27.9% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 0.01 | 0.12 | 0.32 | 1.19 | 2.10 |
| Avg | -0.18 | -0.14 | 0.02 | 0.59 | 1.32 |
| Low | -0.27 | -0.31 | -0.26 | 0.03 | 0.58 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | 7,654.9% | 255.0% |
| Avg | - | - | - | 3,766.7% | 123.3% |
| Low | - | - | - | 92.2% | -2.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.